[1] Respiratory syncytial virus infection of alveolar macrophages in adult transplant patients

[2] Quantitative shedding patterns of respiratory syncytial virus in infants

[3] Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics

[4] Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life

[5] Speculation on pathogenesis in death from respiratory syncytial virus infection

[6] Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients

[7] Increased detection of respiratory syncytial virus, influenza viruses, parainfluenza viruses, and adenoviruses with real-time PCR in samples from patients with respiratory symptoms